Background: A certain number of mutations in the Microtubule-Associated Protein Tau (MAPT) gene have been identified in individuals with high risk to develop neurodegenerative diseases, collectively called tauopathies. The mutation A152TMAPT was recently identified in patients diagnosed with frontotemporal spectrum disorders, including Progressive Supranuclear Palsy (PSP), Frontotemporal Dementia (FTD), Corticobasal Degeneration (CBD), and Alzheimer disease (AD). The A152TMAPT mutation is unusual since it lies within the N-terminal region of Tau protein, far outside the repeat domain that is responsible for physiological Tau-microtubule interactions and pathological Tau aggregation. How A152TMAPT causes neurodegeneration remains elusive.
Background
Neurodegenerative diseases are a leading cause of dementia and pose a serious threat to our aging population. Among them, tauopathies (including AD and FTDP-17) characterized by the accumulation of highly phosphorylated insoluble tau [1] [2] [3] are the most common. Tauopathies can be of two types [4] ; sporadic and familial. A small percentage of patients (1-5 %) develop disease as a result of mutations in the tau gene (MAPT). These mutations can have multifarious consequences; they are capable of reducing the microtubule binding affinity of tau and therefore result in a partial loss of function of tau [5] . Moreover, these mutations are able to increase the beta-propensity of tau, making it more prone to aggregation. Consistent with this, the majority of MAPT mutations studied so far are clustered in or near the repeat domain of tau which is responsible for aggregation [1] . However, a rare point mutation in tau gene (A152T) was recently reported in patients suffering from PSP, FTD, or AD [6] [7] [8] . This mutation is unique since it lies far outside of the repeat domain in the Nterminal proline-rich region which is thought to interact with different signalling pathways due to its interactions with proteins containing SH3-domains [9, 10] .
The amino acid substitution A152T in tau has been shown in vitro to be associated with a reduced microtubule binding affinity and, an increase in formation of Tau oligomers instead of insoluble PHFs [6] . Whether this amino acid substitution has any bearing on the development of disease remains uncertain, due to scarcity of in vivo data. Therefore, to understand the pathological consequences of the A152T mutation in the context of a whole organism, we used the nematode C. elegans as a model. It offers several advantages over other animal models. For example, it has a transparent body with a simple nervous system, which makes it possible to image the progression of pathology at the cellular and sub-cellular level. It has a short life-span (2-3 weeks) and is genetically well characterized and tractable. For these reasons, C. elegans has been extensively used as a model of neurodegeneration [11] [12] [13] and has provided invaluable insights into the nature of the pathology involved. Several key pathways and signalling molecules are conserved between worms and mammals [14] . Two genes implicated in tau pathology (sut-1 and sut-2) have been identified in a genetic screen using C. elegans [15, 16] , which point to effects involving the microtubule and actin cytoskeleton. More recently, we demonstrated the potential of using C. elegans as a tool for the screening of neuroprotective compounds; in fact one of the compounds (MB) that proved beneficial to this model [17] is running in the 3 rd phase of clinical trial [18] . All in all, studies of the C. elegans nervous system have greatly aided efforts to analyze the causes of neurodegenerative diseases on the path to developing an effective treatment.
To investigate the functional consequences of this mutation in vivo, we generated pan-neuronal mutant A152T-tau (htau40A152T, hereafter referred to Tau AT ) and wildtype tau (htau40WT, or Tau wt ) overexpressing nematodes. We found that, while the expression of Tau wt led only to mild pathology over time and in dose-dependent manner, the mutant Tau AT showed pronounced pathology from an early age. The pathology induced by Tau AT was doseindependent, manifested as severe paralysis, defects in the GABAergic motor neurons, accumulation of morphological abnormalities in touch neurons reminiscent of neuronal aging and reduced life span. At the cellular level, Tau AT worms displayed altered distribution of major neuronal organelles (synaptic vesicles and mitochondria) and a perturbed mitochondrial trafficking. The worms expressing Tau AT showed the protein in a pathological state as confirmed by staining with the conformation-dependent MC1 antibody, whereas Tau wt worms showed only minimal staining. Furthermore, in mutant worms Tau AT appeared mostly as soluble higher molecular weight oligomers, albeit they did not accumulate as insoluble aggregates. We also demonstrated that although the mutation site lies in the N-terminal half of Tau AT , the Cterminal half which engages with the microtubules is necessary for pathology.
Results

Expression of mutant Tau
AT leads to severe locomotor defects To examine the consequences of the Tau mutation A152T in vivo, we generated transgenic worms expressing constitutively either the wild-type Tau wt or the Tau AT mutant form of human 2N4R Tau in neurons. The panneuronal expression was achieved using the synaptobrevin promoter snb-1p (Fig. 1a) . Multiple lines were obtained after transgene integration. We first compared the protein levels by subjecting the worm lysates from each strain (3 day old adults) to western blotting using K9JA pan-Tau antibody. Two lines from each set of transgenes were selected for further analysis; worms showing comparably lower expression levels (referred to hereafter as Tau wt -lo or Tau AT -lo, resp.) or higher expression levels (termed Tau (Fig. 1b, c) . Immunostaining with K9JA antibody showed that Tau transgenes were expressed in the entire nervous system, notably in the major ganglion nerve ring and the nerve cords (Fig. 1d , Additional file 9). Non-transgenic animals did not show any staining for human Tau (data not shown).
Worms expressing Tau wt exhibit motor defects with mild uncoordinated (Unc) phenotype characterized by sluggishness and a distorted sinusoidal locomotion relative to non-transgenic worms (Fig. 1e) . However, in worms expressing Tau AT the severe Unc phenotype is much more pronounced than in worms expressing Tau wt . Most of the worms expressing mutant Tau AT were paralytic and were often seen in the coiled state, almost completely unable to move (Fig. 1e) . The extent of motor dysfunction in worms expressing Tau wt correlated with the protein expression levels, Tau wt -lo with lower tau levels showed a milder phenotype (~30 thrashes/30 s) than Tau wt -hi line (~20 thrashes/30 s) with higher tau levels (Fig. 1f , also see Additional file 1: Movie S1 and Additional file 2: Movie S2). By contrast, Tau Tau (2N4R, 441 residues, largest isoform in human CNS) with 2 inserts (N1, N2 near the N-terminus) and 4 repeats (R1-R4 in the C-terminal half) used to generate tau-transgenic lines. The point mutation A152T lies outside of the repeat domain in the proline rich region. The pan-neuronal promoter (Psnb-1) drives the expression of human tau cDNA in the C. elegans nervous system and the 3′UTR aids in tau expression. b Total worm lysates from synchronized day-3 old adults analyzed for Tau by western blotting using pan-tau antibody K9JA. Two independently integrated strains expressing Tau at comparably low and high levels were selected from each transgene: wild-type htau40 (Tau wt -lo and Tau wt -hi) and mutant htau40A152T (Tau   AT   -lo and Tau AT -hi). Tubulin serves as internal control. c Quantification of total tau in wild-type Tau lines (Tau wt -lo and Tau wt -hi) and mutant Tau-A152T lines (Tau  AT -lo and Tau AT -hi). Error bars denote SEM. One-way ANOVA with Tukey's test was applied for multiple comparisons (ns, non-significant, *P < 0.05, **P < 0.01). d Immunochemistry of whole worms with pan-tau K9JA antibody shows tau staining in the nervous system. Top panels depict nerve ring ganglion, bottom panels show ventral cord region. e Synchronized day-1 old adults were placed onto the centre of NGM plates freshly spotted with E. coli OP-50 and photographed after 10 min. Both Tau AT -lo and Tau AT -hi worms show strong paralytic phenotype apparent by their coiled body shape and lack of tracks on the E. coli lawn. The corresponding lines expressing wild-type human tau (Tau wt -lo and Tau wt -hi) possess a mild uncoordinated phenotype and are able to crawl away from the point of origin. f Thrashing assay of synchronized day-1 old adults in liquid. Control worms (non-tg control or worms expressing GFP in the pharynx as transformation marker only) display a high frequency of~50 thrashes/ 30s. Worms expressing Tau wt display a dose-dependent motor impairment with reduced thrashing frequency (~30/30s for Tau wt -lo,~20/30s for Tau wt -hi). Motor impairment is very severe in the worms expressing mutant Tau AT (both -lo and -hi,~2/30s). One-way ANOVA with Tukey's test was applied for multiple comparisons. Error bars denote SEM, n ≥ 30. (ns., non-significant, *P < 0.05, **P < 0.01, ***P < 0.001) toxicity did not correlate with protein expression levels; the Unc phenotype was equally severe in Tau   AT   -lo and  Tau AT -hi worms (Fig. 1f , also see Additional file 3: Movie S3 and Additional file 4: Movie S4). Tau transgenes (Tau   wt   and Tau AT ) when expressed as extrachromosomal arrays showed comparable Tau levels as detected by western blot using K9JA antibody (see Additional file 10), and yielded similar phenotypes as the integrated lines (see Additional file 10), ruling out any effects due to unwanted background mutations during integration.
Mutant Tau
AT leads to pronounced GABAergic neurodegeneration, while Tau wt causes mild degeneration only at higher levels
Normal sinusoidal locomotion in C. elegans is made possible by coordinated activity of reciprocal motor circuits comprised of inhibitory GABAergic and excitatory cholinergic neurons located along the body wall [19] , and any interruption in the networking produces a defective locomotion (uncoordinated). To evaluate the possibility that the locomotion phenotype in tau-transgenic worms is due to a defective motor nervous system, the integrity of GABAergic motor system was monitored. Animals were analyzed for axonal gaps in the ventral and dorsal cords by crossing them into the juIs73:[Punc-25::gfp]III transgene [20] that allows visualization of GABAergic motor neurons by expression of GFP (Fig. 2b) . GABAergic motor neurons in both the worm strains expressing Tau   AT   (Tau   AT   -lo and Tau AT -hi) were severely abnormal with frequent gaps in ventral and dorsal cords, often showing stretches of nerve cords missing (Fig. 2e, F and see Additional file 10, Additional file 11), consistent with the extent of motor dysfunction shown by these worms (see Fig. 1e ). On the other hand, GABAergic motor neurons in worms expressing Tau wt were slightly affected (lesser gaps) when compared to worms expressing Tau AT ( Fig. 2c, d ; Table 1 ). However, when compared to non-tg reporter strain (juIs73), Tau wt worms did exhibit a significant number of gaps (Table 1 
AT induces hallmarks of aging neurons and shortens the life-span
The above microscopical observations of the GABAergic neurons clearly showed that their processes are degenerating, consistent with the locomotor defects seen in Tau-tg worms. As neuronal restructuring and synaptic disintegration is one of the hallmarks of aging nervous system [21, 22] , we asked whether the Tau AT variant initiates such changes which could be interpreted as indication of premature aging of the nervous system. Mechanosensory neurons (touch neurons) offer an excellent model to study changes associated with neuronal aging in C. elegans. These neurons undergo morphological changes such as irregular outgrowths from somata, extra neurites, and bending of main neuronal processes that become exaggerated with age [23, 24] . We therefore generated Tau-tg worms carrying zdIs5:[Pmec-4::GFP + lin-15(+)] transgene that specifically express GFP in the six mechanosensory neurons. We observed significant morphological alterations of these neurons early in adulthood (day 1) of Tau AT worms, changes that have been associated with aging in previous studies [23, 24] . We focussed on ALM neurons (anterior lateral microtubule cells) located in the anterior body region. ALM neuronal processes in Tau AT worms appeared wavy, in contrast to the straight processes seen in non-tg (zdIs5) and Tau wt worms (both Tau wt -lo and Tau wt -hi), and new outgrowths started emanating from the somata already at day 1 (Fig. 3b, panel  day1) . A higher percentage of Tau AT -lo worms (~70 %) showed these morphological abnormalities at day 1 compared to non-tg (~12 %), Tau wt -lo (~20 %) and Tau wt -hi worms (~23 %) (Fig. 3d) . Furthermore, nearly 10 % of non-tg animals showed a single posterior projecting neurite emanating from ALM somata at day 1 consistent with the earlier studies [24] , whereas the incidence of such neurites in Tau (Fig. 3b, panel day1) . However, the number of animals showing ALM neurons with a single posterior projecting neurite was higher in Tau wt worms (~30 %) compared to non-tg animals (~12 %). The severity of these morphological abnormalities further increased with age, new outgrowths that started emanating from ALM somata of day-1 old Tau AT -lo worms had extended to a considerable length and occasionally underwent branching. Furthermore, the single posterior projecting neurite also showed new outgrowths at multiple sites by day 3 of adulthood (example in Fig. 3c, panel day 3) . By this age, about 30 % of the worms expressing Tau wt showed morphological abnormalities similar to day-1 Tau AT worms (Fig. 3d) . A similar trend was seen in PLM neurons (posterior lateral microtubule cells), but the degree of restructuring (accumulated damage) was less extensive (Tau wt -lo:~10 %, Tau wt -hi~20 % and Tau AT -lo:~60 % at day 1). This is consistent with earlier reports whereby neuronal populations were found to differ in terms of vulnerability during aging [24] . Overall our data suggests that the appearance of these morphological changes in neurons that accompany the aging of C. elegans occur early in Tau AT worms compared to Tau wt and non-tg. As previous studies have underlined the role nervous system plays in modulating the lifespan in C. elegans [25] [26] [27] [28] [29] , one would expect a reduced life-span in the worms expressing Tau AT . Ultimately, we assessed the survival of Tau-tg animals ( Fig. 3e) : Tau wt expression resulted in a shorter life-span (~45 % shorter vs. non-tg animals), but mutant Tau AT expression decreased the life-span even much more (~65 % shorter vs. non-tg,~25 % shorter vs. Tau wt (-lo or -hi) ( Table 2) .
Mutant Tau AT worms display perturbed distribution of major neuronal organelles and defective presynaptic neurotransmission
Since Tau AT worms showed early morphological alterations mimicking aging neuronal phenotypes, we sought to investigate the status of the neuronal transport -hi) showed uniform distribution of RAB-3 along axons similar to non-tg (vdEx262) animals at day 1 (Fig. 4b) . In contrast, Tau AT -lo worms showed accumulation of RAB-3 in the distal axon and less RAB-3 puncta in the mid-neuron. Furthermore, posterior minor neurites which are usually devoid of RAB-3 (as seen in non-tg worms, Tau wt -lo and Tau wt -hi worms), were abnormally filled with RAB-3 clusters in Tau AT -lo worms (Fig. 4b) . In older animals, the RAB-3 marker started mislocalizing even in Tau wt worms such that at day 3, RAB-3 was present in minor neurites, similar to day-1 old Tau AT worms show neuronal abnormalities reminiscent of aging neurons. Pmec-4::gfp reporter that expresses GFP in mechanosensory neurons, was crossed into tau-transgenic worms and neurons visualized for morphological abnormalities at the days indicated. Note the soma outgrowth (yellow arrowhead) and bending of neuronal process (white arrow) in Tau AT -lo at day 1. At this age, Tau wt (both -lo and -hi) show normal morphology and do not differ from non-tg. Only the incidence of an infrequent posterior extension (white arrow heads) increases in the Tau wt worms (to 30 % compared with 10 % in non-tg at day 1), whereas in Tau AT -lo this posterior extension occurs in almost 100 % of the animals. c The severity of the phenotype increases with age. Soma outgrowths visible in Tau AT -lo animals at day 1 grow and undergo further branching with age (yellow double arrowhead). The volume marker GFP accumulates in beaded structures in the posterior extension in Tau AT -lo worms and small outgrowths emanate from posterior extension (white double arrowhead). These beaded structures could represent starting points of new branches, and were previously shown to be associated with mitochondria [24] . d Quantification of animals with gross non-specific neuronal abnormalities (bends and branches) at two time points, day 1 and day 3. Error bars denote mean ± SEM, n ≥ 20. **P ≤ 0.01, ***P ≤ 0.001. Paired t-test with unequal variance was used for comparison. e Representative survival curves of tau-transgenic animals, non-tg serves as control. Mantel-Cox log-rank test was performed to determine the statistical significance for the worm life-span. (for P-values see Table 2 ) We sought to clarify whether the mislocalization of mCherry::RAB-3 is due to a disruption in the polarized protein trafficking. To this end, PVD sensory neurons in C. elegans represent suitable test cells because they possess distinct axonal-dendritic compartments, with highly branched dendrites encircling the body, while the axon protrudes to the ventral nerve cord and then grows anteriorly [33, 34] (see schematic in Fig. 5a ). We generated Tau-tg worms carrying kyIs445:Is:[Pdes-2::mCherry::RAB-3;des-2::SAD-1::GFP;odr-1::DsRED] transgene that expresses mCherry fused to RAB-3 in PVD sensory neurons [35] . mCherry::RAB-3 puncta were barely detectable in the PVD dendrites of Tau wt (-lo or -hi) animals, similar to non-tg (kyIs445) worms, with only faint signals detectable in Tau wt -hi at day 1 and increasing with age (Fig. 5b, c) . Contrary to this, in Tau AT worms mCherry::RAB-3 was already mislocalized to the entire PVD dendritic compartment at day 1 (Fig. 5b , panel day1 dendritic). At the same time, the axons of Tau AT worms showed less dense puncta (Fig. 5b , panel day1 axonal). Altered synaptic vesicle distribution could mean that the axonal compartments are compromised in Tau AT worms, implying that there might be a neurotransmission failure at the synapses.
To confirm this, we turned to a complementary approach by using chemicals aldicarb and levamisole that interfere with normal neurotransmission [36] . Aldicarb causes paralysis due to hypercontraction of muscles by inhibiting acetylcholine esterase. Levamisole has a similar effect as an acetylcholine receptor agonist. Normal worms with intact pre-and post-synaptic compartments are sensitive to both chemicals. Worms with either a pre-or a post-synaptic defect show resistance to aldicarb, whereas only worms with a post-synaptic defect show resistance to levamisole. Tau wt -lo and non-tg (N2) worms were sensitive to aldicarb, indicating a normal release of acetylcholine at synapses. However, Tau wt -hi, Tau AT -lo and Tau AT -hi showed a mild resistance to aldicarb (Fig. 5d ). On the other hand, all the tau-transgenic lines were equally sensitive to levamisole and did not differ from non-tg (Fig. 5e ). Thus these experiments argue that the pre-synaptic compartments are compromised in tau-tg worms.
Next we analyzed the distribution of another intracellular organelle, mitochondria. The wyEx2709 [Pitr-1::TOM-20 1-54aa ::yfp] is a transgene that expresses YFP-tagged mitochondria in DA9 motor neurons [37] . AT worms show presynaptic protein mislocalization in dendrites of PVD neurons and neurotransmission defects. a Schematic representation of a PVD neuron with normal localization of mCherry::RAB-3 (pre-synaptic marker, red dots) and a PVD neuron with altered localization. The branched morphology represents the dendritic compartment; the unbranched ventral process is the axon. b Representative images of dendrites and axons at day 1 and day 3 of the mentioned transgenes. In non-tg and Tau wt worms (-lo and -hi), mCherry::RAB-3 localizes in the axonal compartment and is excluded from the dendrites in young adults (day 1). By contrast, Tau AT -lo worms show mCherry::RAB-3 mislocalized to the dendrites (yellow arrowheads) and a reduced distribution in the axons. With age, Tau wt (-lo and -hi) also show slight mislocalization to the dendritic compartments (yellow arrowheads). Yellow dotted areas correspond to the dendrite not visible in non-tg, Tau wt -lo and Tau wt -hi worms at day1. c Quantification of the fractions of animals with mislocalized presynaptic mCherry::RAB-3 puncta in tau-transgenes at day 1 (d1) and day 3 (d3). Non-tg worms serve as control. Error bars denote mean ± SEM, n ≥ 20. **P ≤ 0.01, ***P ≤ 0.001. Paired t-test with unequal variance was used for comparison. d Time-dependent paralysis induced by aldicarb (acetylcholine esterase inhibitor). Data represents the percentage of worms (mean ± SEM) still able to move on 1 mM aldicarb plates after being touched, as a function of time. Non-tg and Tau wt -lo worms are highly sensitive (bottom curves, grey and olive). Tau wt -hi, Tau AT -lo and Tau AT -hi worms show some resistance (blue, ochre, green curves, resp.). Strongly resistant lev-1 (AChR mutant carrying the e211 allele) and mildly resistant rab-3 (Ras GTPase mutant carrying the js49 allele) are used as additional controls (black and red curve, resp). After applying two-way ANOVA with Bonferroni correction, P < 0.01 at time points 45 and 180 min, whereas P < 0.001 at time points 90 and 135 min is obtained for Tau wt -hi, Tau AT -lo and Tau AT -hi against non-tg. n = 20 animals, three independent repetitions. e Time-dependent paralysis induced by levamisole (acetylcholine receptor agonist). Data represents the percentage of worms (mean ± SEM) still able to move on 0.2 mM levamisole plates after being touched, as a function of time. All the four tau-lines were as sensitive to levamisole as non-tg. Strongly resistant lev-1 (e211) is shown as an additional control. n = 20 animals, three independent repetitions The DA9 soma lies in the preanal ganglion; it has a well defined dendrite extending anterioventrally and an axon that crosses the body to reach the dorsal cord and then runs anteriodorsally. Non-tg animals display a typical distribution of labelled mitochondria (schematic in Fig. 6a , [37] ; such that the anteriodorsal region (boxed area,~90 μm, Fig. 6a ) contains closely spaced (~5-10 μm) mitochondria, as seen in the non-tg reporter strain (wyEx2709) (Fig. 6b, panel non-tg) . But away from the anteriodorsal region towards the distal end, the spacing between the mitochondrial particles increases (~30-50 μm) (data not shown). We then visualized mitochondria in our tau-tg animals by crossing them into wyEx2709. Tau ::yfp] reporter that highlights YFP-tagged mitochondria in DA9 motor neurons. Magnified images of the region corresponding to the proximal axon (boxed area in the schematic) are shown to visualize the faint mitochondrial particles (yellow arrowheads). Mitochondrial particles in day-3 old adult worms of the transgenes (right panel). Areas in white marked by asterisk shows body autofluorescence. c, d, and e Quantification of the average number of mitochondria in different regions of DA9 neurons designated as proximal axon (boxed region), distal axon (away from boxed region) and dendrite. Tau AT -lo animals exhibit fewer mitochondria than non-tg and Tau wt worms in all the specified compartments of the neuron at day 1 and day 3. Error bars show mean ± SEM, n ≥ 20. **P ≤ 0.01, ***P ≤ 0.001. Paired t-test with unequal variance was used for comparison Tau wt -lo and Tau wt -hi at both the time points (day 1 and day 3) (Fig. 6b) . However, compared to non-tg animals, Tau wt expression led to an increase in mitochondria in a dose dependent manner. This effect was more pronounced in the distal axon, where Tau wt -hi worms showed~1.7 fold increase in mitochondrial number compared to Tau wt -lo (Fig. 6c, d, e) . Collectively, these results show that the mutant Tau AT distorts the normal distribution of neuronal cargoes in C. elegans neurons.
Altered mitochondrial distribution in mutant Tau
AT worms is due to a defective transport Altered steady state distribution of major neuronal cargoes (synaptic vesicles and mitochondria) in Tau AT animals is likely due to impaired neuronal transport machinery. To investigate the effect of Tau AT , we performed mitochondrial trafficking analysis by generating Tau-tg worms carrying jsIs609 transgene [17] which expresses GFP fused to a mitochondrial localization signal (MLS) in mechanosensory neurons. In order to get an insight into how the transport machinery is affected in different parts of neurons, we chose two regions, one close to the cell body (up to~80 μm from the cell body) and another in the mid region (120 μm away from the cell body) (refer to Fig. 4a) , and recorded mitochondrial movements in a time frame of 2.5 min. -lo worms showed a decrease in the number of trafficking events, especially in the proximal region (~30-35 % reduction), whereas Tau wt -hi and Tau AT -lo did not display a drastic change in the trafficking events in either of the regions with age (Fig. 7b, c) .
In conclusion, Tau AT -lo worms showed a severe defect in mitochondrial transport compared to non-tg and Tau wt animals, which provides a plausible explanation for the altered steady state distribution of neuronal cargoes in the worms expressing mutant Tau AT .
Mutant Tau
AT adopts a pathological conformation but does not form insoluble aggregates
A common feature of neurodegenerative diseases is protein aggregation. There is an ongoing debate regarding the nature of the toxic species, e.g. the relatively stable insoluble aggregates which could obstruct the cellular space, or soluble aggregates in the form of oligomers [38] [39] [40] . To address this question for the case of the Tau AT mutant, we first biochemically extracted tau from day-1 old worms [17] . Soluble fractions were completely extracted first by using a salt buffer (RAB), which removes most of the soluble cytoplasmic fraction, followed by a detergent buffer (RIPA), which removes proteinprotein or protein-membrane complexes. The detergent insoluble pellet was finally reextracted with urea buffer (Urea). Neither Tau wt nor Tau AT accumulated detergent insoluble tau at day-1 (Additional file 13). Next we extracted tau from mixed stage worms consisting mostly of > 3 days old ones. Here we used CK10 line which is transgenic for htau V337M (1N4R) and is known to accumulate detergent insoluble tau with age (mixed stage) as a positive control [41] . The CK10 line but not Tau wt or Tau AT showed tau in the detergent insoluble fraction (Fig. 8a) , although there was an increase in the detergent soluble Tau fraction in Tau   wt   and Tau AT with age compared to the day-1 old adults (see Additional file 13 for comparison).
To confirm our results, we generated another line expressing a Tau chimaera with two additional proline substitutions in the hexapeptide motifs (I277P and I308P), besides the A152T mutation (termed Tau AT+PP ) (Fig. 8b) . The proline substitutions make this Tau chimaera inherently incapable of forming detergent insoluble Tau filaments because they block the amyloidogenic β-structure [42] . We then compared the protein levels in the worms carrying Tau wt , Tau AT or Tau AT+PP transgenes as extrachromosomal arrays at day 1, all of which showed comparable levels of Tau protein (Fig. 8c) expectations, Tau AT+PP resulted to be equally toxic and the Tau AT+PP worms were as paralytic as single mutant Tau AT worms (Fig. 8d,e) . This argues that the toxicity does not depend on the formation of β-structure and incipient aggregation, in contrast to the pro-aggregant mutation ΔK280 described earlier [17, 43] .
Before the accumulation of insoluble aggregates as tangles, Tau is known to undergo a change towards a pathological conformation which accompanies oligomerization during the pre-tangle state and can be recognized by antibodies Alz-50 or MC-1 [44] . Using MC-1 staining, we confirmed pathological conformation and observed an extensive staining of nerve ring ganglion and nerve cords in Tau AT -lo worms. By contrast, Tau wt (-lo and -hi) worms showed only minimal staining (Fig. 8f ) and non-tg worms showed no staining (data not shown). Since it was reported previously that Tau AT mutant tau has a higher tendency to form oligomers in vitro [6] , we wanted to test if such oligomeric species also exist in Tau AT worms. To detect oligomers, we applied native PAGE to analyze total lysate extracted from the mixed stage worms in buffer C (see Methods) using K9JA antibody. Lysate from Tau wt -lo showed protein accumulated in two bands (~170 KDa and >250 KDa marked by asterisk in Fig. 8g ). By contrast, the lysate from Tau AT -lo showed in addition a higher band (Fig. 8g , black arrowhead) at the top of the gel and a smear in the range of 72-95 KDa (Fig. 8g, line) , meaning that Tau AT worms accumulate a broad range of higher molecular weight tau species compared to Tau wt worms. Lysate from non-tg worms on the other hand did not show any reaction to K9JA antibody. We conclude that the mutation A152T favors a pathological conformation which might promote oligomerization.
The toxicity of mutant Tau
AT is not prevented by antiaggregation compounds
The conclusion that the toxicity of A152T mutation occurred independently of the β-propensity of the repeat domain was corroborated by treatment of Tau AT -lo worms with inhibitors of Tau aggregation (Rhodanine compound bb14 and PTH compound BSc3094), that were competent to ameliorate the phenotype of a worm model based on tau aggregation [17] . The Tau AT -lo worms were treated with varying concentrations of compounds in liquid culture for three days, starting from the L1 larval stage. However, the compounds failed to improve the paralytic phenotype of the Tau AT -lo worms (Fig. 8h) . This implies that the principle behind the pathological features observed in Tau AT worms is perhaps different from that of the conventional Tau-aggregation.
The C-terminal half of Tau including the repeat domain is necessary for the toxicity of human tau in C. elegans neurons
The repeat domain of tau in the C-terminal domain harbors the primary physiological and pathological functions of tau, stabilization of microtubules and formation of aggregates in disease [45, 46] . Much less is known about the functions of the N-terminal domain; but it is known to interact with motor proteins and signalling proteins [9, [47] [48] [49] . Additionally, the pathological conformation adopted by tau is achieved as a result of intramolecular folding of C-terminal against the N-terminal (See figure on previous page.) Fig. 8 AT is based on some mechanism distinct from aggregation (for comparison see [17] ). Error bars denote SEM. One-way ANOVA with Tukey's test applied for multiple comparisons (ns., not significant) domains (discontiguous epitope MC-1, residues 5-15 + 312-322) [44] . Furthermore, mimicking the posttranslational modifications at epitopes of antibodies AT8, AT100 and PHF-1 (upstream and downstream of the repeats, resp.) leads to a change of the paperclip folding of Tau that is known to consolidate the MC-1 epitope [50] . Since the A152T mutation lies in the Nterminal projection domain of tau, we wondered if Nterminal tau domains that lack a potential MC-1 epitope would still produce a similar phenotype as the fulllength tau. We generated transgenic worms expressing pan-neuronally the N-terminal tau (Nt-tau) chimaeras (Met 1 -Leu 243 ) with or without the mutation A152T (Fig. 9a) (Fig. 9b) . In spite of these high levels, the N-terminal tau fragments produced only a slight reduction in mobility (thrashes) compared to nontg at day1 and day 5, and the difference became statistically insignificant at day 7 (Fig. 9c) . These results are consistent with earlier findings where an N-terminal fragment of Tau expressed in mouse brain produced phenotypically normal mice [48] .
We then performed staining of worms expressing the N-terminal tau fragments with the polyclonal antibody SA4473 specific for the N-terminal half of tau. Nt-tau fragments in these worms showed extensive staining exclusively in somata and nuclei, but were largely excluded from the neuronal processes (Fig. 9d) . These results ) cause only slight reductions (~10-13 %) in thrashing at day 1 and day 5. The data points represent the mean (±SEM) thrashing rate and time point, n ≥ 30. Two-way ANOVA followed by Bonferroni correction was used for multiple comparisons. d Immunostaining of animals expressing either wild-type-or mutant-N-t tau fragments at different time points with N-terminal tau-specific antibody SA4473. Top panels depict nerve ring ganglion while the bottom panels show nerve cords. N-terminal Tau fragments show localization restricted to cell bodies and nuclei (white arrows), as nerve processes are largely invisible, in contrast to the situation with full-length Tau (see Fig. 1c) show that N-terminal tau fragments which are unable to move into the neuronal processes are not toxic to C. elegans neurons. Thus a mild uncoordinated phenotype due to Tau wt and a strong paralytic phenotype due to Tau AT could both be abolished by preventing the Tau chimaeras to move into the neuronal processes. In conclusion, a severe toxicity occurs only when both conditions are met; (a) presence in neuronal processes, (b) A152T mutation. Therefore, we speculate that it might be the ability of full-length tau to move into different neuronal processes owing to its C-terminal half that makes it toxic and the A152T mutation further aggravates the problem, whereas restricting its localization to the cell body by abolishing the C-terminal half renders it non-toxic, even in the mutant form. Table 3 sums up the data on the effect of various Tau variants when expressed pan-neuronally in C. elegans.
Discussion
In this study we used a C.elegans model to examine the toxicity of a rare mutation in the MAPT gene (A152TMAPT) that was recently discovered as a risk factor for frontotemporal dementia spectrum disorders (FTD, PSP, CBD, AD, and others) [51] . Considering that most Tau mutations lie in or near the repeat domain and thus affect Tau-microtubule binding and Tau aggregation, the A152T mutation is unusual in that it lies in the proline-rich region far upstream of the repeat domain [7, 8] , with only weak effects on Tau aggregation [6] . This poses the question of an alternative mechanism of toxicity. Over the years, several functions have been assigned to the N-terminal domain of tau which do not coincide with the functions of the repeat domain [9] . Examples of interactors with the N-terminal domain are p150/Dynactin [47, 52] , or signalling kinases containing SH3 domains [48, 49, 53] , which point to functions distinct from microtubule stabilization.
We found that elevation of wild-type human Tau (Tau wt ) in C. elegans neurons is already mildly toxic and can induce late-onset pathology in a dose-dependent manner, consistent with results from mouse models of AD [54] . However, mutant Tau AT at similar levels induces a much more pronounced pathology with an early onset. These worms developed severe motor dysfunction, paralysis and neurodegeneration of GABAergic neuronal processes (Figs. 1 and 2 ). Since we observed neurodegeneration in motor neurons, a condition often associated with old age in humans [55] , we hypothesized that Tau AT could cause effects similar to those observed in aging neurons. This can be tested on mechanosensory neurons by well-defined parameters [24] , and indeed the neurons of Tau AT worms showed early signs of morphological abnormalities such as bendings and extra outgrowths from neuronal processes and somata (Fig. 3b, c) compared to non-tg and Tau wt worms. The severity of these morphological abnormalities increased with age (Fig. 3c) . Moreover, these signs of early aging on the level of Tau AT -expressing neurons corresponded to a drastic reduction in life-span of the animals as well (Fig. 3e) . Since mutations in genes that reduce the lifespan also cause early onset of age-dependent morphological abnormalities in neurons [23, 24, 56] , it is safe to speculate that the pathways that are involved in inducing such age-dependent morphological abnormalities might get activated early in Tau AT worms. However, some alternate pathways that induce similar morphological changes in neurons independently of aging have also been reported [23, 34] .
What could be the reasons behind the neuronal dysfunction and age-related phenotypes in Tau AT worms? Tau interacts with microtubules, microtubules are the tracks for intracellular transport, and defects in neuronal transport machinery have been linked to neurodegeneration. This led us to search for signs of transport defects in the neurons of Tau AT worms. This was done for the cases of two major neuronal cargoes, namely synaptic vesicle (carrying Rab-3 GTPase) and mitochondria [57] . The Tau AT worms presented a perturbed distribution of both of these cargoes. For example, mCherry::RAB-3 puncta accumulated in distal axons and in cell bodies but were depleted in the mid region of mechanosensory neurons (Fig. 4, Additional file 12) , consistent with Transgenic lines based on different Tau constructs are compared to the non-transgenic control (N2) animals defective retrograde and anterograde transport [58] [59] [60] . Moreover, not only the transport but the integrity of the neuronal compartments was compromised in mutant Tau AT worms as suggested by the mislocalization of mCherry::RAB-3 in the dendritic compartments of polarized PVD neurons (Fig. 5b, c) [33, 35] .
Polarized sorting of synaptic vesicles requires ankyrin (UNC-44) driven anchoring of CRMP (UNC-33) into axons, which in turn drives plus-end directed microtubules extending into the axons and subsequent plus-end directed axonal traffic by kinesin (UNC-104) [35] . The observed missorting of synaptic vesicle associated RAB-3 into dendrites of Tau AT worms could be caused by several factors, e.g. more plus-end directed microtubules in dendrites, or mislocalization of ankyrin (UNC-44) and subsequent localization of CRMP (UNC-33) into dendrites, both of which are normally excluded from this compartment. The resulting changes in the dendritic microtubular network due to CRMP could then trigger kinesin (UNC-104) dependent traffic into the dendrites. Future studies should reveal if this phenomenon in Tau AT worms is related to a direct interaction of tau with ankyrin (UNC-44) or CRMP (UNC-33). In addition to the microtubular network, tau is also known to interact and directly or indirectly influence the dynamics of the actin cytoskeleton [61] , and this cross-talk with the microtubule-and actincytoskeleton might play a critical role in tau-induced neurodegeneration [62] . In line with these findings, two suppressors (sut-1 and sut-2) have been identified in a genetic screen using C. elegans [15, 16] . Although a direct interaction between tau and SUT-1 or SUT-2 is not known; however, both of these proteins interact with proteins associated with either microtubule-based or actin-based cytoskeletal systems.
A similar correlation was seen with mitochondrial particles tagged with YFP in DA9 motor neurons. Mutant Tau AT worms showed less mitochondrial particles in the synaptic areas of DA9 axons. Time-resolved imaging revealed that this perturbed mitochondrial distribution is due to a decreased mitochondrial trafficking in Tau AT worms (Figs. 6 and 7) . This perturbed distribution of neuronal organelles is analogous to the previous C. elegans kinesin/dynein double mutant studies which reported an overall decrease in the number density of synaptic vesicles along the axonal processes and accumulation of very few vesicles in the end neurons. This can be explained by the fact that both retrograde and anterograde transport processes are affected in a kinesin/dynein double mutant. On the other hand, the expression of Tau wt generated a phenotype analogous to a dynein mutant where a deficient retrograde transport leads to the accumulation of synaptic vesicles along the distal part of the axon [59, 60] . These transport deficits might also explain the extensive neuronal restructuring of the touch neurons in Tau AT animals (Fig. 3) . The fact that most of these non-specific branches grew directly from the cell bodies supports the view that mitochondria accumulate in the cell bodies which may provide local energy for new outgrowths. Occasionally these nonspecific branches in touch neurons of Tau AT worms underwent further branching, consistent with earlier studies that attributed this phenomenon to ROS production by static dysfunctional mitochondria [24] . Overtime, even wild-type Tau wt worms started showing these phenotypes, albeit to a lesser extent.
It is worth noting that in certain assays, Tau wt and Tau AT worms did not differ much, possibly because a threshold in these phenotypic assays is lower and even the wild-type tau was able to cross that threshold, albeit at higher levels. For instance, Tau wt at higher levels led to pre-synaptic defects similar to Tau AT at both lower and higher levels (Fig. 5d, e) . Similarly, there was no change in the phosphorylation status of tau in both Tau wt and Tau AT worms (Additional file 14). This indicates that there is no special preference for mutant tau with regard to phosphorylation by C. elegans kinases and further suggests that tau phosphorylation may not be a cause for toxicity. In addition, neither Tau wt nor Tau AT worms accumulated insoluble tau (Fig. 8a) . Aggregation is usually considered a hallmark of Tauopathies such as AD, PSP, or CBD, but there is also persuasive evidence that the toxic species are not the fully developed insoluble and aggregated forms of the protein but earlier soluble oligomeric precursors [63] [64] [65] . We therefore searched for assembly forms of Tau AT in the transgenic worms. The results showed that there are no detectable insoluble aggregates (as judged by the usual standard isolation procedures), but an increase in soluble oligomeric forms. In this regard, the Tau AT are distinct from other cases where aggregation-prone Tau mutants were expressed and accumulated in the insoluble fraction in C. elegans neurons, e.g. mutants V337M or ΔK280 [17, 41] . The absence of insoluble aggregates was further confirmed in two ways: (i) by expressing an inherently aggregation-incompetent Tau construct with two proline substitutions in the hexapeptide motifs plus the A152T mutation which yielded a similar phenotype as a tau construct with the A152T mutation alone (Fig. 8 d, e) ; and (ii) by treating the Tau AT worms with known aggregation inhibitor compounds, which offered no relief (Fig. 8h) , in contrast to worms expressing pro-aggregant forms of Tau [17] . These experiments argue that the toxic principle of Tau AT does not depend on aggregation. Important to mention here is that another line expressing a full-length htau40A152T chimaera with an additional V337M mutation (Ex that the A152T mutation lies in a region important for scaffolding and signalling pathways, it further suggests that the mutation leads to a toxic gain of function distinct from aberrant aggregation. Indeed, the Tau AT worms showed strong staining with antibody MC-1 (Fig. 8f) , a characteristic feature of pathological conformational changes [44] . Thus the situation is reminiscent of other neurodegenerative conditions where soluble pre-aggregates are the primary culprits behind the toxicity [66] [67] [68] . In line with these findings, tau in A152T worms was detected mostly enriched in the soluble higher molecular weight species (potential oligomers) by native PAGE (Fig. 8g) . A growing body of evidence suggests that a cell combats the decline of proteostasis due to toxic gain of function of proteins by sequestering soluble proteins into insoluble aggregates [69, 70] . The fact that Tau AT worms have a short life-span (Fig. 3e ) might explain that there is not enough time to sequester and circumvent toxic effects caused by soluble diffusible tau. It would be of interest to investigate whether an increase of life-span, e.g. by suppressing insulin-signalling [71] , would allow them to drive these soluble tau species into insoluble aggregates, and subsequently whether the pathological consequences are alleviated.
One important finding of this study was that the Tau AT mutant does not induce pathology unless tau moves into the neuronal processes. It appears that C. elegans neurons can easily cope with a tau chimaera, irrespective of whether it is wild-type or a A152T mutant, provided that its localization is restricted to the cell body. The evidence is that when expressing wild-type or A152T mutant N-terminal tau fragments without the repeat domain, their localization was restricted to cell body (Fig. 9d) . The explanation is that the fragments cannot engage to the microtubule-based transport machinery since they lack the MT-binding domain [72] . Both these lines were almost as healthy as the non-tg lines (Fig. 9c) , even though the N-terminal fragments were expressed at a 5-10 fold higher level than fulllength tau (Fig. 9b) . Secondly, a full-length variant of Tau with two additional proline substitutions in the hexapeptide motifs (Tau AT+PP ) which is incompetent for aggregation, but otherwise is transported normally into cell processes (Additional file 15), induces pathology to the same extent as that of Tau AT (Fig. 8e) . This supports earlier findings in mice showing that tau needs to move out of the cell body in order to exert its toxic effects [48] . In the light of the current interest in the cell-to-cell spreading of Tau it would be interesting to know whether the intercellular propagation of Tau AT could contribute to the toxicity. However, this issue cannot be addressed in the current model, as mutant Tau is expressed pan-neuronally.
Taken together, the detailed description of the pathology due to the Tau AT mutation provided by the new worm models opens up multiple possibilities to identify cellular components involved in the Tau-dependent pathology and might contribute to the development of novel therapeutic interventions of tauopathies.
Conclusions
In this study, we present a new C. elegans model to understand the pathological consequences of A152TMAPT mutation, recently identified in patients diagnosed with frontotemporal spectrum disorders, including PSP, FTD, CBD, and AD. Using this model we found that, while the wild-type human tau (Tau wt , 2N4R) overexpression in C. elegans neurons induces a progressive mild locomotor defects in a dose-dependent manner, mutant tau (Tau A152T , 2N4R) induces a severe paralysis accompanied by acute neuronal dysfunction. Tau A152T worms show morphological alterations in neurons similar to what has been reported in aging neurons and exhibit a reduced life-span. Tau A152T overexpressing neurons show mislocalization of cellular organelles and disrupted mitochondrial trafficking. Importantly, Tau A152T remains in a pathological conformation but does not accumulate as insoluble aggregates. Moreover, the C-terminal domain of tau which engages with the microtubules is necessary to induce pathology despite the fact that the A152T mutation lies in the N-terminal domain. Together these data show that the mutant Tau A152T overexpression in C. elegans neurons induces pathology that is not dependent on aggregation.
Methods
Plasmid constructs
To generate A152T cDNA [6] , we used site-directed mutagenesis (Stratagene QuikChange reagents) to introduce the point mutation A152T into htau40WT cDNA. The respective cDNAs encoding wild-type htau40WT and mutant htau40A152T were ligated into SalI and KpnI sites of pPD49.26 vector between the snb-1 promoter and unc-54 3′-UTR (a generous gift from Dr. B.C. Kraemer, University of Washington, Seattle). Two additional proline substitutions were introduced into mutant htau40A152T in the hexapeptide motifs (I277P and I308P, intended to break beta-structure) [73] . The resulting cDNA was cloned into SalI and KpnI sites of pPD49.26 as described above, yielding Psnb-1::htau40A152T(I 277 P)(I 308 P). Similarly, another Tau chimaera with A152T plus V337M mutation was generated as described above and cloned into SaII and KpnI sites of pPD49.26, yielding Psnb-1::htau40A152TV337M. As the A152T mutation lies outside the repeat region of Tau in the N-terminal domain, we also generated worms expressing only the N-terminal regions of tau, residues 1-243. We cloned the first 243 amino acid region of wildtype and mutant tau cDNA into the BamHI and KpnI sites of pPD49.26 to generate the transgene constructs Psnb-1::N ′t-htauWT Met1-Leu243 and Psnb-1::N′t-htauA152T
Met1-Leu243
respectively. All plasmid constructs were confirmed by DNA sequencing.
Generation of transgenic lines
Complex arrays were generated by injection of Tau transgenes along with a coinjection marker (Pmyo-2::gfp or Pmyo-2::mCherry, gift of Dr. R. Baumeister) into the gonad of N2 (Bristol) at 75 ng/μl. Coinjection markers were used at a concentration of 20 ng/μl and also served as controls when injected alone at the same concentrations. To generate the stable lines, the transgenes were integrated by exposing the animals to 300 J/m 2 UV dose [74] . Multiple stable transgenic lines were isolated, and before proceeding further, the transgenic lines were backcrossed to N2 wild-type at least five times to eliminate any background mutations.
C. elegans maintenance and crosses were performed according to the standard methods [75] . Worms were cultured at 20°C unless otherwise specified. N2 Bristol was used as the wild-type C. elegans. The following transgenic strains were used: PIR1: pirEx1[Psnb-1::htau40WT;Pmyo- 
Behavioral assays
For qualitative locomotor behavior, synchronized day-1 old adults were placed onto the center of NGM plates freshly spotted with E. coli OP-50 and photographed after 10 min. For thrash assays, synchronized animals from each transgenic line were transferred into 20 μl of M9 buffer (22 mM KH 2 PO 4 , 42 mM Na 2 HPO 4 , 86 mM NaCl and 1 mM MgSO 4 ) on a glass slide. After allowing the animals to settle for 1 min, the frequency of body bending was counted for 30 s [76] .
Life span assay
A synchronous population of worms was obtained by extracting eggs from gravid adults and incubated in M9 buffer overnight. Synchronised L1 larvae were collected and allowed to grow until late L4 stage on regular NGM plates seeded with E. coli OP50, and then transferred onto OP50 seeded NGM plates containing 0.05 mg/ml FUDR (5-fluoro-2-deoxyuridine) for the first two days to inhibit growth of progeny. Thereafter, the worms were grown again on regular OP50 seeded NGM plates and scored every two days by tugging gently on the tail with a platinum wire covered with bacteria. Worms that failed to respond to touch were scored as dead. GraphPad Prism software was used to perform the statistical analysis.
Immunohistochemistry
Worms were permeabilized by freeze cracking after fixation in 2 % paraformaldehyde solution as described previously [58] . Polyclonal rabbit pan-tau antibody (K9JA; Dako A-0024) at a dilution of 1:5000 was used to detect Tau. To monitor the conformational changes, we used the pathological conformation-specific monoclonal mouse antibody MC-1 [77] ; (gift from Dr. P. Davies; 1:20). For immunostaining of worms expressing N-terminal tau fragments, rabbit polyclonal antibody SA4473 (Eurogentec; 1:300) was used. Respective secondary antibodies were used at 1:350 dilutions. Stained animals were imaged at 63x using a Zeiss inverted epifluorescence microscope.
Imaging
GABAergic motor neurons were imaged by mounting immobilized young adult animals in 50 mM sodium azide (Sigma) on glass slides with 2 % agarose pads, and imaged using a 20x or 40x objective on LSM700 (Zeiss). To study the steady state distribution of synaptic vesicles, worms were anesthetized in 50 mM sodium azide, mounted on 2 % agarose pads, and neurons were imaged at 63x with Zeiss inverted epifluorescence microscope. For steady state imaging of mitochondrial marker Pitr-1:TOM-20 1-54aa ::yfp, we used Nikon microscope equipped with Andor Spinning Disc Setup and EM-CCD camera (Andor iXon 3). For live imaging of GFP tagged mitochondria, worms of appropriate age (day-1 and day-3 old adult) were anesthetized in 2-3 mM of levamisole (Biomol) [58] and mounted on 2 % agarose pads. Time lapse (3fps) images of mitochondria tagged with GFP in mechanosensory neurons were acquired at 63x with a Zeiss epifluorescence microscope equipped with a CCD (Photometrics) camera. Images were acquired for constant time (t = 2.5 min) in two different regions of a neuron, in the proximal part (axonal part adjacent to cell body,~60-80 μm) and middle part~120 μm away from cell body (refer to schematic in Fig. 4a ). The number of moving mitochondrial events was counted manually for each genotype from the acquired movies. Representative kymographs were generated using an ImageJ (NIH) plug in.
Aldicarb and levamisole assays
To perform the aldicarb (acetylcholine esterase inhibitor) and levamisole (acetylcholine receptor agonist) sensitivity assays, day-1 old adult worms were transferred to plates containing 1 mM aldicarb and 0.2 mM levamisole, respectively and the time course of paralysis was assayed as described previously [36, 78] . 20 animals per strain were scored for paralysis and each experiment was repeated three times.
Pharmacological treatment
Chemical treatment was applied in liquid cultures as described earlier [17] . Aggregation inhibitor compounds bb14 (Rhodanine) or BSc3094 (PTH) were dissolved in DMSO and added to the liquid culture at 50 and 100 μM concentrations.
Protein extraction
To extract total Tau protein, synchronized worms were washed off NGM plates with water and the bacteria were removed in the subsequent washing steps. The resulting worm pellets (~100 mg) were resuspended in 1X protein sample buffer containing 355 mM 2-mercaptoethanol and boiled at 96°C for 10 min. with continuous shaking at 14,000 rpm. To determine the accumulation of insoluble tau aggregates, a slight modification of the previous extraction protocol [17] was performed using buffers of increasing stringency. Briefly, after removing the dead animals and bacteria by flotation on a 30 % sucrose solution, worm pellets (~100 mg) were resuspended in twice the amount (w/v) of high-salt RAB buffer [100 mM 2-(N-morpholino) ethanesulfonic acid (MES), 1 mM EGTA, 0.5 mM MgSO 4 , 20 mM NaF]. Worm pellets were lysed completely by sonication (6 × 10 s, 10 s break) on ice, and homogenates centrifuged at 40,000 g for 40 min. The supernatant is the soluble RAB fraction. RAB pellet was sonicated for 10 s in 1 M sucrose containing RAB buffer and centrifuged for 20 min at 40,000 g, and the supernatant was discarded. The pellet was extracted with RIPA buffer (150 mM NaCl, 1 % Nonidet P-40, 0.5 % deoxycholate, 0.1 % SDS, 50 mM Tris, pH 8.0) and centrifuged at 40,000 g for 20 min. The supernatant constitutes the detergent soluble RIPA fraction. The resulting pellet, after a brief washing with RIPA buffer, was extracted with urea containing buffer (UREA) [30 mM Tris, 7 M urea, 2 M thiourea, 4 % CHAPS (3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate), pH 8.5] and centrifuged at 13,000 g for 15 min. The supernatant is the detergent insoluble fraction.
For native PAGE, frozen worm pellets (~100 mg) were resuspended in buffer C (20 mM Hepes, pH 7.9, 25 % glycerol, 0.42 M NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA, 0.5 mM DTT) and lysed by sonication (2 × 10 s, 10 s break) on ice. After a brief centrifugation at 40,000 g for 5 min, the supernatants were analyzed on 4-12 % native PAGE. The entire extraction procedures were carried out on ice and centrifugation steps were at 4°C. All buffers contained Complete Protease Inhibitor Mixture 3× (Sigma-Aldrich P8340, Hamburg, Germany), 1 μM okadaic acid (phosphatase inhibitor) and 0.5 mM PMSF (protease inhibitor).
Supplementary methods
Immunoblotting Worm fractions (total or sequentially extracted -salt soluble, detergent soluble or detergent insoluble) were migrated in 10 % polyacrylamide gels, transferred to nitrocellulose membranes (Immobilon) and immunoblotted. The following antibodies were used: DM1α-tubulin (1:500; Sigma), K9JA (1:20,000; no. A0024; Dako), AT8 (1:500; Thermo Scientific), PHF-1 (1:500; a gift from Dr. P. Davies, Albert Einstein College, Bronx, USA), 12E8 (1:500; Dr. P. Seubert, Elan Pharmaceuticals, South San Francisco, USA), AT180 (1:500; Thermo Scientific), AT100 (1:500; Thermo Scientific). For worms expressing the N-terminal region of tau, antibody DA9 (raised against aa100-130, a gift from Dr. P. Davies) was used at a dilution of 1:250. Peroxide-conjugated secondary antibodies and ECL solution (Thermo Scientific) were used to visualize the blots. AIDA software (Raytest, Germany) was used to perform densitometry. 
